No abstract available
Keywords:
CTLC-4; Cancer; PD-L1; immunotherapy.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antigen-Presenting Cells / immunology
-
CD8-Positive T-Lymphocytes / immunology
-
CTLA-4 Antigen / antagonists & inhibitors
-
Cell Death
-
Dendritic Cells / immunology
-
Immunotherapy / adverse effects
-
Immunotherapy / methods*
-
Ipilimumab / therapeutic use
-
Lymph Nodes / immunology
-
Neoplasms / drug therapy*
-
Neoplasms / immunology
-
Programmed Cell Death 1 Receptor / physiology
-
Receptors, Antigen, T-Cell / immunology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
CTLA-4 Antigen
-
Ipilimumab
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Receptors, Antigen, T-Cell
-
tremelimumab